Samala, NiharikaTersey, Sarah A.Chalasani, NagaAnderson, Ryan M.Mirmira, Raghavendra G.2017-09-202017-09-202017Samala, N., Tersey, S. A., Chalasani, N., Anderson, R. M., & Mirmira, R. G. (2017). Molecular Mechanisms of Nonalcoholic Fatty Liver Disease: Potential Role for 12-Lipoxygenase. Journal of Diabetes and Its Complications. https://doi.org/10.1016/j.jdiacomp.2017.07.014https://hdl.handle.net/1805/14125Nonalcoholic fatty liver disease (NAFLD) is a spectrum of pathologies associated with fat accumulation in the liver. NAFLD is the most common cause of liver disease in the United States, affecting up to a third of the general population. It is commonly associated with features of metabolic syndrome, particularly insulin resistance. NAFLD shares the basic pathogenic mechanisms with obesity and insulin resistance, such as mitochondrial, oxidative and endoplasmic reticulum stress. Lipoxygenases catalyze the conversion of poly-unsaturated fatty acids in the plasma membrane—mainly arachidonic acid and linoleic acid—to produce oxidized pro-inflammatory lipid intermediates. 12-Lipoxygenase (12-LOX) has been studied extensively in setting of inflammation and insulin resistance. As insulin resistance is closely associated with development of NAFLD, the role of 12-LOX in pathogenesis of NAFLD has received increasing attention in recent years. In this review we discuss the role of 12-LOX in NAFLD pathogenesis and its potential role in emerging new therapeutics.enPublisher Policynon-alcoholic fatty liver diseaselipoxygenaseoxidative stressArticle